We are live on !
Find out more
FA
Forefront Analytics Portfolio holdings
AUM
$92M
Turnover
5.13%
1-Year Est. Return
25.18%
This Fund
S&P 500
This Quarter Est. Return
+14.39%
1 Year Est. Return
+25.18%
3 Year Est. Return
+50.89%
5 Year Est. Return
+36.12%
10 Year Est. Return
–
AUM
$92M
AUM Growth
-$17.9M
(-16%)
Cap. Flow
-$31.5M
Cap. Flow % of AUM
Cap. Flow %
-34.18%
Top 10 Holdings %
Top 10 Hldgs %
82.69%
Holding
39
New
–
Increased
19
Reduced
15
Closed
2
Avg Time Held
4
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.09M |
| 2 |
Danaher
DHR
|
+$137K |
| 3 |
Pfizer
PFE
|
+$134K |
| 4 |
Incyte
INCY
|
+$85.1K |
| 5 |
iShares Core High Dividend ETF
HDV
|
+$63.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares ESG Aware MSCI EAFE ETF
ESGD
|
+$15.3M |
| 2 |
iShares ESG Aware MSCI EM ETF
ESGE
|
+$9.25M |
| 3 |
Northern Trust STOXX Global ESG Select ETF
ESGG
|
+$5.02M |
| 4 |
Nuveen ESG Large-Cap Value ETF
NULV
|
+$2.71M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$236K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.11% |
| 2 | Healthcare | 5.43% |
| 3 | Technology | 4.25% |
| 4 | Financials | 2.11% |
| 5 | Industrials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $10.8M | 11.7% |
180,376
+214
| +0.1% | +$12.6K |
2017 Q4
34 quarters
|
|
|
2
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.8B
| $10.7M | 11.65% |
104,247
-150,180
| -59% | -$15.3M |
2025 Q2
4 quarters
|
|
|
3
iShares ESG Aware MSCI EM ETF
ESGE
$6.51B
| $10.5M | 11.43% |
192,398
-177,055
| -48% | -$9.25M |
2025 Q2
4 quarters
|
|
|
4
iShares Core High Dividend ETF
HDV
$15.5B
| $9.39M | 10.21% |
342,756
+2,321
| +0.7% | +$63.1K |
2018 Q4
30 quarters
|
|
5
iShares MSCI USA Momentum Factor ETF
MTUM
$18.7B
| $8.38M | 9.1% |
24,434
+200
| +0.8% | +$59.7K |
2018 Q4
30 quarters
|
|
|
6
Nuveen ESG Large-Cap Value ETF
NULV
$2.57B
| $7.04M | 7.65% |
140,912
-54,745
| -28% | -$2.71M |
2024 Q1
9 quarters
|
|
7
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.21B
| $6.92M | 7.52% |
126,734
-158
| -0.1% | -$8.27K |
2017 Q4
34 quarters
|
|
|
8
Northern Trust STOXX Global ESG Select ETF
ESGG
$118M
| $5.05M | 5.49% |
21,669
-22,570
| -51% | -$5.02M |
2025 Q3
3 quarters
|
|
|
9
NVIDIA
NVDA
$5.24T
| $3.91M | 4.25% |
19,532
+5,291
| +37% | +$1.09M |
2020 Q1
25 quarters
|
|
10
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $3.39M | 3.68% |
47,559
+252
| +0.5% | +$17.6K |
2017 Q4
34 quarters
|
|
11
iShares Core S&P 500 ETF
IVV
$884B
| $3.33M | 3.62% |
4,450
-24
| -0.5% | -$17.5K |
2017 Q4
34 quarters
|
|
12
iShares Currency Hedged MSCI Emerging Markets
HEEM
$286M
| $2.6M | 2.83% |
58,203
-337
| -0.6% | -$14.2K |
2017 Q4
34 quarters
|
|
13
JPMorgan Chase
JPM
$886B
| $1.64M | 1.78% |
4,997
+13
| +0.3% | +$4.04K |
2017 Q4
34 quarters
|
|
14
Deere & Co
DE
$169B
| $743K | 0.81% |
1,172
+36
| +3% | +$20.9K |
2020 Q3
23 quarters
|
|
15
UnitedHealth
UNH
$365B
| $586K | 0.64% |
1,409
-574
| -29% | -$213K |
2022 Q3
15 quarters
|
|
|
16
Incyte
INCY
$23B
| $577K | 0.63% |
5,091
+858
| +20% | +$85.1K |
2022 Q4
14 quarters
|
|
17
Edwards Lifesciences
EW
$50.3B
| $557K | 0.61% |
6,158
-416
| -6% | -$34.8K |
2024 Q3
7 quarters
|
|
18
ProShares Ultra S&P500
SSO
$8.94B
| $551K | 0.6% |
8,180
+16
| +0.2% | +$1.02K |
2024 Q4
6 quarters
|
|
19
ProShares Ultra Russell2000
UWM
$204M
| $538K | 0.58% |
7,997
+7
| +0.1% | +$416 |
2017 Q4
34 quarters
|
|
20
Abbott
ABT
$180B
| $514K | 0.56% |
5,665
+622
| +12% | +$56.8K |
2025 Q2
4 quarters
|
|
21
WisdomTree US SmallCap Earnings Fund
EES
$675M
| $476K | 0.52% |
7,020
-1,212
| -15% | -$76.9K |
2017 Q4
34 quarters
|
|
|
22
Pfizer
PFE
$168B
| $438K | 0.48% |
18,210
+5,120
| +39% | +$134K |
2021 Q4
18 quarters
|
|
23
Medtronic
MDT
$119B
| $416K | 0.45% |
5,319
| – | – |
2024 Q3
7 quarters
|
|
|
24
Danaher
DHR
$158B
| $389K | 0.42% |
2,040
+752
| +58% | +$137K |
2025 Q3
3 quarters
|
|
25
Thermo Fisher Scientific
TMO
$251B
| $336K | 0.36% |
669
+90
| +16% | +$43.2K |
2025 Q4
2 quarters
|
|
Similar funds
VI
GBA
PBCM
HI
DCA
SWP
SAM
Forefront Analytics's Q2 2026 Portfolio in Review
As of Q2 2026, Forefront Analytics held 39 positions worth $92M, down 16% from $110M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Forefront Analytics withdrew a net $31.5M in Q2 2026, closing 2 positions and reducing 15 holdings. Its most notable exit was U.S. Small Cap Value Portfolio ETF Class Shares, an estimated $222K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 91% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Forefront Analytics added an estimated $1.09M to NVIDIA.
- Forefront Analytics added most to NVIDIA in Q2 2026, an estimated $1.09M increase.
- Forefront Analytics's biggest Q2 2026 reduction was iShares ESG Aware MSCI EAFE ETF, cutting an estimated $15.3M.
- Forefront Analytics fully exited U.S. Small Cap Value Portfolio ETF Class Shares in Q2 2026, selling an estimated $222K.
- Forefront Analytics's ten largest holdings make up 83% of its $92M portfolio in Q2 2026.
- Forefront Analytics opened 0 new positions and closed 2 in Q2 2026.
- Forefront Analytics's portfolio value fell 16% quarter-over-quarter to $92M.
Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.